Quince Therapeutics Investor Relations Material
Latest events
Investor Update
Quince Therapeutics
Investor Presentation
25 Jun, 2025
Q1 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Quince Therapeutics Inc
Access all reports
Quince Therapeutics Inc is a U.S.-based biopharmaceutical company focused on the development and commercialization of targeted therapeutics for debilitating and rare diseases. The company’s pipeline includes treatments designed to improve drug delivery and tissue targeting for enhanced efficacy and safety. Quince Therapeutics leverages proprietary platforms and collaborates with partners to advance its clinical and preclinical programs. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Quince Therapeutics Inc
Investor Presentation
Quince Therapeutics Inc
Investor Presentation
Quince Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
QNCX
Country
🇺🇸 United States